Both antibodies, however, are capable of specifically precipitating PSMA from a prostate carcinoma cell line and, notably, also lung squamous cell carcinoma (SCC) tumor samples (Fig EV1B and C). Here, FOLH1 is linked to squamous cell lung carcinoma.